Sirolimus-Eluting Iron Bioresorbable Scaffolds vs Everolimus-Eluting Stents for Percutaneous Coronary Intervention: A Randomized Trial (IRONMAN II)

Journal:

Journal of the American College of Cardiology

Published:

2026-02-11

DOI:

10.1016/j.jacc.2025.12.024

Affiliations:

22

Authors:

28

Go to article

Institutions	Authors	Share
Fuwai Hospital, CAMS & PUMC, China	5.666667	0.20
Fuwai Yunnan Cardiovascular Hospital, China	2.000000	0.07
General Hospital of Northern Theater Command of PLA, China	2.000000	0.07
Zhongshan Hospital, Fudan University, China	2.000000	0.07
National Center for Cardiovascular Diseases (NCCD) at Fuwai Hospital, CAMS & PUMC, China	1.333333	0.05
Sir Run Run Shaw Hospital (SRRSH), Zhejiang University School of Medicine, China	1.000000	0.04
General Hospital of Ningxia Medical University, China	1.000000	0.04
West China School of Medicine/West China Hospital of Sichuan University (WCSM/WCH), SCU, China	1.000000	0.04
Guangdong Academy of Medical Sciences (Guangdong Provincial People’s Hospital), China	1.000000	0.04
Renmin Hospital of Wuhan University/Hubei General Hospital, China	1.000000	0.04
Xuzhou Cancer Hospital, China	1.000000	0.04
First Hospital of Lanzhou University, LZU, China	1.000000	0.04
Northern Jiangsu People's Hospital, China	1.000000	0.04
The Sixth Medical Center, PLAGH, China	1.000000	0.04
First Affiliated Hospital of Xinjiang Medical University, China	1.000000	0.04
Beijing Anzhen Hospital, Capital Medical University, China	1.000000	0.04
The First Hospital of Hebei Medical University, HEBMU, China	1.000000	0.04
The Inner Mongolia Autonomous Region People's Hospital, China	1.000000	0.04
The First Affiliated Hospital of Xi'an Jiaotong University, XJTU, China	1.000000	0.04
Icahn School of Medicine at Mount Sinai (ISMMS), MSHS, United States of America (USA)	1.000000	0.04

Interested in Cardiovascular Medicine and Haematology?